Broughton Pharma

Active Biotech AB (publ) (NASDAQ Stockholm: ACTI) is a biotechnology company that deploys its extensive knowledge base and portfolio of compounds to develop first-in-class immunomodulatory treatments for specialist oncology and immunology indications with a high unmet medical need and significant commercial potential. Following a portfolio refocus, the business model of Active Biotech aims to advance projects to the clinical development phase and then further develop the programs internally or pursue in partnership. Active Biotech currently holds three projects in its portfolio: Naptumomab, a targeted anti-cancer immunotherapy, partnered to NeoTX Therapeutics, is in a phase Ib/II clinical program in patients with advanced solid tumors. The small molecule immunomodulators, tasquinimod and laquinimod, both having a mode of actions that includes modulation of myeloid immune cell function, are targeted towards hematological malignancies and inflammatory eye disorders, respectively. Tasquinimod, is in clinical phase Ib/IIa for treatment of multiple myeloma. Laquinimod is advancing to a clinical phase I study with a topical ophthalmic formulation, to be followed by phase II for treatment of non-infectious uveitis. Please visit www.activebiotech.com for more information.

Idifarma is a Contract Development and Manufacturing Organization (CDMO) for small molecule oral drug development and manufacturing, with high potency and spray drying capabilities.

Idifarma is part of Ardena, your one-source partner to help you navigate the drug development process from molecule to clinic.

Ardena is a pharmaceutical CDMO that guides companies through the drug discovery and development process to help create effective and compliant drug substance and products for clinical trials.

Ardena provides you with an integrated service offering including solid state chemistry, API & nanomedicines development and manufacturing, analytical & formulation development, drug product manufacturing, bioanalytical, drug discovery and dossier development services.

Headquartered in Ghent, we have facilities in the Netherlands, Belgium, Sweden Latvia and Spain, serving a global customer base, ranging from emerging biotech to tier-one pharmaceutical companies.

We understand the complex challenges involved in taking a promising molecule from lab to patient.
Each project we undertake is preceded by a detailed planning phase to ensure that the right work is carried out at the right time. This staged approach allows you to stagger your investments and mitigate risks during each phase of the project.

Our integrated offering is the engine that drives all of our projects. Our multidisciplinary team is keen to streamline your development process.

We also make sure that all the work we do for you is compliant with the appropriate regulatory standards as you move along the clinical development path. Our dossier-centric approach is key to help you compile your regulatory dossier in a timely and cost-efficient manner. By preparing your regulatory dossier in parallel with drug development, we ultimately get your drug to patients faster.

Transforming proteins into pioneering drugs

ProJect Pharmaceutics, based in Martinsried/Munich, Germany, transforms proteins, peptides and delicate small molecules into pioneering drugs. ProJect Pharmaceutics adds value to client´s bio-pharmaceutical products by applying an innovative concept of development called Advaceutics. Based on the Advaceutics concept, ProJect Pharmaceutics designs optimized formulations and delivery systems for biologics that are stable, convenient and safe. Tailored to these optimized systems the company develops cost-effective manufacturing processes and transfers those from its own pilot labs to large-scale manufacturing. ProJect Pharmaceutics makes sure that investigational products, biosimilars as well as “bio-betters” are developed effectively and will run smoothly in clinical and commercial scale GMP manufacturing.

We offer:
• predictive formulation analytics
• formulation development including in-depth protein analytics
• lyophilization process development and optimization
• lyophilization in dual chamber prefilled syringe
• development of liposomal formulations, producible by simple stirring
• manufacturing of preclinical study material
• technology-transfer including scale-up to GMP-manufacturer

We deliver:
• optimized formulations for biopharmaceuticals
• tailored manufacturing processes and transfer to GMP manufacturing
• development reports ready for submission to the authorities for registration

Oroxcell is an independent research organization (CRO) offering research services assessing the safety, toxicity and efficacy of active ingredients and finished formulations.

Specialized in in-vitro testing, particularly in 3D Human Models, Oroxcell is developing its business on two fronts:

• Safety & efficacy testing: From screening to GLP Compliant studies, we provide well established In-vitro platform, 2D and 3D models, for performing routine and regulatory safety testing, ADME (Absorption, Distribution, Metabolism, and Elimination) and Toxicity (sensitization, phototoxicity and genotoxicity) tests, bioanalytical studies, for evaluating pharmaceuticals, medical devices, cosmetics, nutraceuticals, home care and chemical products.

• Research & Innovation: Oroxcell provides a wide range of services including R&D project management and technical support, international consortium setup and management and regulatory & toxicology consulting.
We assist you in selecting or developing the best alternative testing methods for your safety and efficacy issues.

Oroxcell has been certified GLP compliant (Grade A, the highest grade) since 2011 by the French National Medicines and Cosmetics Safety Agency, ANSM.


Website: http://www.oroxcell.com
Contact: contact@oroxcell.com

Accepta is an innovative, industry leading chemical technology specialist serving global environmental, municipal and industrial process markets. Working closely with industry our specialist advisers combine world-class technical expertise with our own advanced treatment technologies to create practical solutions to resolve complex problems.

Accepta’s comprehensive product range is fully supported by teams of highly trained technical specialists and includes high performance chemical treatment products, analysis equipment, laboratory services, dosing pumps, meters and control equipment.

Our advanced; scientifically formulated range of speciality chemicals incorporates water treatment chemicals for steam boilers, cooling towers, cooling water systems and closed circuits; wastewater and effluent treatment chemicals, high performance industrial cleaning and janitorial chemicals, advanced polymers, state-of-the-art solid chemicals, reverse osmosis membrane products, eco-friendly biological formulations and much more.

Our high performance water quality analysis equipment is designed for chemists, microbiologists, water treatment and facilities management specialists who need to accurately test and monitor the quality of water and other aqueous solutions.

Our pumps, meters and control equipment are used extensively in a wide range of demanding commercial, industrial and process applications where reliability, accuracy, and long term performance are essential.